Colt:
Firstly I'll have you note that I'm not a medically trained person. Obviously I'm happy for anyone qualified to correct my interpretation.
I understand from the literature that 68Ga-labeled prostate-specific membrane antigen (PSMA-11) PET/CT detects recurrent prostate cancer with sensitivity superior to standard-of-care imaging. So this trial (of a relatively small sample of 25 men selected) compared the results of the baseline 68Ga analysis to the results using 64Cu SAR-bombesin.
A considerable number of the patients were found to have negative results based on 68Ga but 64Cu demonstrated sites of disease recurrence in 44% of those negative cases. This adds further weight to the suggestion that 64Cu is a superior diagnostic tool for the detection of prostate cancer in certain instances.
- Forums
- ASX - By Stock
- Research/Valuation
Colt:Firstly I'll have you note that I'm not a medically trained...
-
- There are more pages in this discussion • 76 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
|
|||||
Last
$7.51 |
Change
0.030(0.40%) |
Mkt cap ! $2.371B |
Open | High | Low | Value | Volume |
$7.47 | $7.55 | $7.44 | $6.874M | 917.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 256 | $7.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.52 | 23925 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 256 | 7.510 |
2 | 16033 | 7.480 |
6 | 36363 | 7.450 |
2 | 13570 | 7.440 |
3 | 7980 | 7.430 |
Price($) | Vol. | No. |
---|---|---|
7.520 | 23925 | 1 |
7.530 | 1967 | 1 |
7.540 | 2718 | 2 |
7.550 | 7634 | 3 |
7.570 | 4634 | 1 |
Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |